BMS-866949

N/A

Report date: 2026/05/16 20:00:17
NME

Base Information

Drug NameBMS-866949
Drug Alias NameBMS-866949CSTI-500AMR-001181
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNorepinephrine transporter inhibitorsDopamine transporter antagonistsSerotonin transporter inhibitors
TargetsNorepinephrine transporterDopamine transporterSerotonin transporter
Therapy Area/IndicationsDepressive Disorder, MajorDepressionPrader-Willi Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSweden
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlbany Molecular Research Inc
China Registration ClassN/A

Develop Information

Active CompaniesConsynance Therapeutics
Inactive CompaniesBristol Myers Squibb Srlcompany
Active IndicationsPrader-Willi Syndrome
Inactive IndicationsDepressive Disorder, MajorDepression

Other Information

ATC CodeN/A
Related LinksN/A